"Sadhana Nitro Granted Environmental Clearance for Paracetamol Ingredient Production"
In a significant development, Sadhana Nitro Chem Ltd has obtained environmental regulatory clearance to produce pAP (Para Aminophenol), a crucial... Full Story
Browse All News by Date
Bristol Myers Squibb to invest Rs. 800 cr for drug development in Hyderabad.
Bristol Myers Squibb, a world's leading biopharmaceutical company will establish a state of-the-art site here to expand its global drug... Full Story
More Top Stories
LATEST HEADLINES FROM MIDDLE EAST AND NORTH AFRICA
"Rusan Pharma Allocates INR 300 Crores for New API Facility in Pithampur, Madhya Pradesh"
Pithampur, Madhya Pradesh, witnessed the inauguration of Rusan Pharma's state-of-the-art active pharmaceutical ingredient (API) facility recently. The pharmaceutical company has invested Rs. 300 crore in... Full Story
Pharmacies to be set up at 270 stations in Eastern Railway zone: Official.
Healthcare facilities such as pharmacies and collection centres for pathology laboratories will be established at 270 stations in the Eastern Railway zone by the end... Full Story
Solara receives EDQM CEP approval for its API unit in Vishakhapatnam.
Solara Active Pharma Sciences announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received 'Certificate of Suitability'... Full Story
IIL to set up new animal vaccine unit in Hyderabad at ₹700 cr.
Indian Immunologicals Limited (IIL) will invest about ₹700 crore in setting up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad. The new plant... Full Story
Lincoln Pharmaceuticals acquires Cephalosporin plant in Mehsana.
Lincoln Pharmaceuticals Limited recently announced the acquisition of a Cephalosporin manufacturing plant in Mehsana.
Lincoln will launch Cephalosporin products - antibiotics - soon, it said.
The company plans to... Full Story
Torrent acquires Elder unit for Rs. 2,000 crore.
Ahmedabad-based Torrent is set to acquire Mumbai-based Elder Pharma's entire domestic formulations business in India and Nepal for Rs. 2,004 crore, making it the first... Full Story
Intas Pharma is planning to raise R2. 50Cr PE investment for expansion
Intas Pharma is planning to raise R250Cr private equity investment for expansion.
Intas Pharma filed DRHP to raise upto R425Cr through fresh issue of shares.
The company... Full Story
Ranbaxy gets approval for drugs treating seizures
New Delhi: Ranbaxy Laboratories has received approval from the US Food and Drug Administration (USFDA) to market and manufacture a generic drug for treating seizures.... Full Story
This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2024